The effects of continuous administration of supraphysiologic doses of
dexamethasone (DEX) on bone metabolism were examined in rats. Adult, m
ale, Sprague Dawley rats were infused with DEX at a constant rate of 1
6.25 mu g/day for 19 days. Despite soft tissue catabolism, DEX treatme
nt led to a significant increase in bone volume in all experiments. Th
is was accompanied by a significant gain in femoral weight and calcium
content. These findings were also observed in DEX-treated parathyroid
ectomized animals indicating that intact parathyroid function was not
required for this effect. DEX treatment did not affect mean levels of
serum calcium or phosphorus but led to significant declines in circula
ting levels of PTH and 1,25(OH)(2)D and in the urinary calcium/creatin
ine ratio. This latter finding was also observed in PTX animals in whi
ch 1,25(OH)(2)D levels did not change. Serum concentrations of osteoca
lcin and tartrate-resistant acid phosphatase both declined in a time-d
ependent manner with DEX treatment suggesting a slowing of bone turnov
er with the net effect favoring formation. However, histomorphometric
findings were variable. Two of three experiments demonstrated a decrea
se in cellular parameters of formation and resorption and in one exper
iment, these indices increased. Mineralized surface increased with DEX
treatment. We conclude that, in marked contrast to the findings in ma
n and certain other species, DEX treatment increases bone mass in rats
. This may in part relate to a relatively greater suppression of resor
ption vis a vis formation.